Bristol-Myers Squibb Acquires iPierian, Inc.
The acquisition gives Bristol-Myers Squibb full rights to iPierian’s lead asset IPN007, an innovative preclinical monoclonal antibody that represents a ...
Tuesday, October 6, 2026
ADVERTISEMENT
Tag: iPierian
FasterCapital backs a rice production project through EquityPilot
FasterCapital has added a rice production and processing startup to EquityPilot, the firm’s execution-focused program designed to help early-stage ventures...
Read moreDetails
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.